ISRG vs V: Which Is the Better Buy?

Side-by-side comparison of Intuitive Surgical, Inc. and Visa Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-22.
Intuitive Surgical, Inc. Β· Healthcare
$451.29
+130.4% upside to fair value
Grade B High Quality
VS
Visa Inc. Β· Financial Services
$304.36
+37.7% upside to fair value
High Conviction Grade A-
QuantHub Verdict
ISRG has more upside to fair value (+130.4%). V trades at a lower forward P/E (23.7x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric ISRG V
Current Price $451.29 $304.36
Fair Value Estimate $1,039.74 $419.00
Upside to Fair Value +130.4% +37.7%
Market Cap $160.3B $586.8B
Forward P/E 53.8x 23.7x
EV / EBITDA 40.5x 22.3x
Price / Sales 15.2x 14.2x
Price / FCF 64.3x 25.6x
Revenue Growth YoY +23.0% +11.3%
Gross Margin 66.3% 81.08%
Operating Margin 30.5% 59.18%
Return on Equity 17.0% 54.22%
Dividend Yield 0% 0.83%
FCF Yield 1.55% 3.91%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
ISRG β€” Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading healthcare company specializing in robotic-assisted surgery through its flagship da Vinci system, which has established a durable competitive moat with approximately 10,000 systems installed globally and nearly 17 million procedures performed by the end of 2024. The company benefits from a high-quality business model characterized by 85% recurring revenue, st…
V β€” Visa Inc.
Visa is the world's dominant payment network with $40B in net revenue (FY2025), 50%+ net margins, and a capital-light toll-booth model processing $14.2T in annual payment volume across 257.5B transactions. The business compounds at 10-12% revenue CAGR with operating leverage pushing EPS growth to 12-15% over a cycle, funded by $21.6B in annual free cash flow against only $1.5B in capex. At 28.0x …
Accumulation Zones
Metric ISRG V
Zone Low $779.81 $265.00
Zone High $883.78 $300.00
In Buy Zone? Yes No
← ISRG Research    V Research β†’    All Research